5-(4-联苯)戊醇 | 120756-57-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-(4-联苯)戊醇
• 英文名称: 4-(5-hydroxypentyl)-1,1'-biphenyl
• 英文别名: [1,1'-biphenyl]-4-pentanol；5-(4-phenylphenyl)pentan-1-ol
• CAS: 120756-57-2
• 化学式: C₁₇H₂₀O
• mdl: MFCD04038126
• 分子量: 240.345
• InChiKey: GKFQLFNRJVCOFP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.294
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

制备方法与用途

用途

基因工程学研究用试剂

反应信息

• 作为反应物：
  描述：

  5-(4-联苯)戊醇 在 potassium dihydrogenphosphate 、 N-溴代丁二酰亚胺(NBS) 、 sodium methylate 、 三苯基膦 作用下， 以 乙醚 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 38.59h， 生成 Methyl 3-cyano-3-hydroxy-4-[5-(4-phenylphenyl)pentylsulfanyl]butanoate
  参考文献：
  名称：

  ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme

  摘要：

  ATP-citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Inhibitors of the enzyme represent a potentially novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic and hypotriglyceridemic properties. A series of a-substituted butanedioic acids have been designed and synthesized as inhibitors of the enzyme, The best compounds, 58, 68, 71, 74 have reversible K-i's in the 1-3 mu M range against the isolated rat enzyme, As representative of this compound class, 58, has been shown to exert its inhibitory action through a mainly competitive mechanism with respect to citrate and a noncompetitive one with respect to CoA. None of the inhibitors were able to inhibit cholesterol and/or fatty acid synthesis in HepG2 cells. This has been attributed to the adverse physicochemical properties of the molecules leading to a lack of cell penetration. Despite this, a lead structural class of compound has been identified with the potential for modification into potent, cell-penetrant, and efficacious inhibitors of ATP-citrate lyase.

  DOI：

  10.1021/jm960167w
• 作为产物：
  描述：

  对苯基苯甲醛 在 lithium hydroxide monohydrate 、 palladium on activated charcoal 、 氢气 、 二异丁基氢化铝 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 24.0h， 生成 5-(4-联苯)戊醇
  参考文献：
  名称：

  在分子对接计算和分子动力学模拟的指导下，开发了一种有效的分泌型磷脂酶A2的2-氧酰胺抑制剂。

  摘要：

  抑制IIA组分泌的磷脂酶A2（GIIA sPLA2）已成为药物化学家的重要目标。先前我们已经表明，结合了2-氧酰胺功能的抑制剂可能会抑制人和小鼠GIIA sPLA2。在此，描述了使用已知的抑制剂7的结构通过分子对接计算来开发新的有效抑制剂的方法。新化合物的合成和生物学评估表明，基于（S）-缬氨酸GK241的长链2-氧代酰胺可提高活性（分别针对人和小鼠GIIA sPLA2的IC50 = 143nM和68nM）。此外，采用分子动力学模拟来阐明GK241的有效和选择性抑制活性。

  DOI：

  10.1016/j.bmc.2016.02.040

文献信息

• Zwitterionic Sulfobetaine Inhibitors of Squalene Synthase
  作者：Thomas A. Spencer、Thomas J. Onofrey、Reginald O. Cann、Jonathon S. Russel、Laura E. Lee、Daniel E. Blanchard、Alfredo Castro、Peide Gu、Guojian Jiang、Ishaiahu Shechter

  DOI：10.1021/jo981617q

  日期：1999.2.1

  A substantial number of sulfobetaines (e.g., 10) have been synthesized and evaluated as inhibitors of squalene synthase (SS) on the basis of the idea that their zwitterionic structure would have properties conducive both to binding in the active site and to passage through cell membranes. When the simple sulfobetaine moiety is incorporated into compounds containing hydrophobic portions like those in

  已经合成了大量的磺基甜菜碱（例如10种），并根据其两性离子结构具有有助于在活性位点结合和通过细胞膜通过的特性，被认为是鲨烯合酶（SS）的抑制剂。 。当将简单的磺基甜菜碱部分掺入含有疏水部分的化合物中时，如法呢基二磷酸酯（1）或角鲨烯二磷酸酯（2）中的那些，确实在大鼠肝微粒体测定中观察到了SS的抑制作用。例如，法呢基化磺基甜菜碱10具有抑制SS的IC（50）＝10μM，而芳香族衍生物35具有IC（50）＝2μM。研究了多种结构修饰，例如化合物43、52、76、85、91、99、111和115。不幸，
• Nickel-catalyzed C–N bond activation: activated primary amines as alkylating reagents in reductive cross-coupling
  作者：Huifeng Yue、Chen Zhu、Li Shen、Qiuyang Geng、Katharina J. Hock、Tingting Yuan、Luigi Cavallo、Magnus Rueping

  DOI：10.1039/c9sc00783k

  日期：——

  Nickel-catalyzed reductive cross coupling of activated primary amines with aryl halides under mild reaction conditions has been achieved for the first time. Due to the avoidance of stoichiometric organometallic reagents and external bases, the scope regarding both coupling partners is broad. Thus, a wide range of substrates, natural products and drugs with diverse functional groups are tolerated. Moreover

  首次实现了在温和反应条件下镍催化的活化伯胺与芳基卤化物的还原交叉偶联。由于避免了化学计量的有机金属试剂和外部碱，因此两种偶联伙伴的范围很广。因此，可以耐受多种底物、天然产物和具有不同官能团的药物。此外，还进行了实验机理研究和密度泛函理论（DFT）计算与波函数分析相结合，以更详细地了解催化循环。
• 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
  申请人：Tsubouchi Hidetsugu

  公开号：US20060094767A1

  公开（公告）日：2006-05-04

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物，其通式如下：其中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R2代表—OR3或类似的基团，R3代表氢原子、C1-C6烷基或类似的基团，或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环，其通式为（H）：其中，R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
• Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
  申请人：Gibbs A. Richard

  公开号：US20070004803A1

  公开（公告）日：2007-01-04

  The present invention relates to a novel method for the treatment of neoplasia, including cancer and other diseases and conditions in humans and mammals. More particularly, in preferred aspects, the present invention provides a method for the use of prenylcysteine analogs for the treatment of neoplasia, hyperproliferative cell growth including psoriasis, restenosis following cardiovascular surgery, hyperplasia, including renal hyperplasia, chronic inflammatory diseases including rheumatoid and osteoarthritis, among others.

  本发明涉及一种新的治疗肿瘤的方法，包括癌症和其他人类和哺乳动物疾病和病况的治疗。更具体地，在首选方面，本发明提供了一种使用戊二烯基半胱氨酸类似物治疗肿瘤、包括牛皮癣、心血管手术后再狭窄、包括肾脏增生的增生、包括类风湿和骨关节炎等慢性炎症疾病的方法。
• Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
  申请人：Crooks Peter

  公开号：US20100113511A1

  公开（公告）日：2010-05-06

  Provided are monoquaternary ammonium compounds which are modulators of nicotinic acetylcholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse, and or gastrointestinal tract disorders.

  提供了单季铵化合物，它们是尼古丁乙酰胆碱受体的调节剂。还提供了使用这些化合物调节尼古丁乙酰胆碱受体功能，以及预防和/或治疗中枢神经系统疾病、物质使用和/或滥用以及胃肠道疾病的方法。